Current status of perioperative beta blocker therapy in Germany - Results of a postal survey;Stellenwert der perioperativen betablockade in Deutschland - Ergebnisse einer fragebogenaktion

Anasthesiologie und Intensivmedizin

Volumn 47, Issue 4, 2006, Pages 203-212

  Suttner, Stephan ^a   Boldt, J ^a   Wolf, M ^a   Papsdorf, M ^a   Lang, K ^a   Piper, S ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Cardiac Risk; Coronary Heart Disease; Perioperative Adrenergic Receptor Blockade; Survey

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HEART DISEASE; HUMAN; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; QUESTIONNAIRE; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

EID: 33646380592     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Statistisches Bundesamt Wiesbaden. Todesursachenstatistik 2002. Pressemitteilung vom 27. Januar 2004. http://www.destatis.de/presse/deutsch/ pm2004/p0410092.htm
2. Hamm CW. Leitlinien: Akutes Koronarsyndrom (ACS) - Teil 1: ACS ohne persistierende ST-Hebung. Z Kardiol 2004; 93: 72-90
3. Mangano DT. Adverse outcomes after surgery in the year 2001 - a continuing odyssey. Anesthesiology 1998; 88: 561-4
4. Charlson M, Peterson J, Szatrowski TP, MacKenzie R, Gold J. Long-term prognosis after perioperative cardiac complications. J Clin Epidemiol 1994; 47: 1389-1400
5. Böttiger BW, Martin E. Prevention perioperativer Myokardischämien. Anaesthesist 2000; 49: 174-86
6. American College of Physicians. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 1997; 127: 309-12
7. Eagle KA, Berger PB, Calkins H, et al. for the American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary. Circulation 2002; 105: 1257-67
8. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996; 335: 1713
9. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, Miller D, Mangano DT, McSPI Research Group. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 1998; 88: 7-17
10. Poldermans D, Boersma E, Bax JJ, et al. The effects of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341: 1789-94
11. Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of betaadrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth 2002; 88: 101-23
12. London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative betaadrenergic receptor blockade - physiologic foundations and clinical controversies. Anesthesiology 2004; 100: 170-5
13. Kertai MD, Bax JJ, Klein J, Poldermans D. Is there any reason to withhold betablockers from high-risk patients with coronary artery disease during surgery? Anesthesiology 2004; 100: 4-7
14. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339: 489-97
15. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Betablockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318: 1730-37
16. CIBIS II Investigators and Committees. The cardiac insufficiency bisoprolol study II: a randomized trial. Lancet 1999; 353: 9-13
17. Packer M, Coats AJS, Fowler MB, et al. for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-8
18. VanDenKerkhof EG, Milne B, Parlow JL. Knowledge and practice regarding prophylactic beta blockade in patients undergoing noncardiac surgery: A survey of Canadian anesthesiologists. Anesth Analg 2003; 96: 1558-65
19. Price DJ, Kluger MT, Fletcher T. The management of patients with ischemic heart disease undergoing noncardiac elective surgery: A survey of Australian and New Zealand clinical practice. Anaesthesia 2004; 59: 428-34
20. Stone JG, Foex P, Sear JW, et al. Myocardial ischemia in untreated hypertensive patients: effects of a single small dose of a beta-adrenergic blocking agent. Anesthesiology 1988; 68: 495-500
21. Poldermans D, Boersma E, Bax JJ, et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001; 22: 1353-8
22. Shammash, JB, Trost JC, Gold JM, et al. Perioperative betablocker withdrawal and mortality in vascular surgery patients. Am Heart J 2001; 141: 148-53
23. Auerbach AD, Goldman L. Betablockers and reduction of cardiac events in noncardiac surgery - scientific review. JAMA 2002; 287: 1435-44
24. Priebe HJ. Perioperative myocardial infarction-aetiology and prevention. Br J Anaesth 2005; 95: 3-19.
25. London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies. Anesthesiology 2004; 100: 170-5.
26. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349-61.
27. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9.